Home・Stock List・Pulse Biosciences Inc

Pulse Biosciences Inc

Open

SectorHealthcare

37.65 7.63

Buy Sell

Overview

Share price change

24h

Current

Min

34.98

Max

37.47

Key metrics
By Trading Economics
Income	-1.1M -19M
Sales	137K 401K
EPS	-0.241
Profit margin	-4,633.666
Employees	116
EBITDA	-1.7M -19M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	-4.64% downside

Dividends
By Acuity
Next Earnings	6 Aug 2026

Market Stats
By TradingEconomics
Market Cap	729M 2.3B
Previous open	30.02
Previous close	37.65

News Sentiment

By Acuity

50%

132 / 340 Healthcare

Pulse Biosciences Inc Chart

Past performance is not a reliable indicator of future results.

Related News

31 Jul 2026, 19:16 UTC

Pulse Biosciences Inc is gaining during Friday's session, reaching a high above Thursday's close. The stock remains above its 20-day moving average.

30 Jul 2026, 20:09 UTC

Event

Pulse Biosciences' NANOPULSE-AF Study enrollment surpasses midpoint, supporting stock gains since Wednesday. Shares remain above the 20-day moving average amid market volatility.

29 Jul 2026, 22:03 UTC

Event

Pulse Biosciences shares are lower in after-market hours despite surpassing enrollment midpoint in its NANOPULSE-AF Study, reflecting broader cautious market sentiment.

28 Jul 2026, 23:46 UTC

Pulse Biosciences Inc shares are lower in after-market trading, reflecting volatility amid broader market declines, though no specific news was identified.

27 Jul 2026, 19:51 UTC

Pulse Biosciences Inc shares are higher today amid unusually high trading volume, despite earlier downward movement. No specific news was identified to explain the move.

24 Jul 2026, 18:11 UTC

Pulse Biosciences Inc shares are lower today, breaking a trend of higher daily closes. The stock is trading with unusually high market volume.

22 Jul 2026, 19:31 UTC

Pulse Biosciences shares are higher today amid increased trading volume, despite earlier pulling back from session highs. No specific news was identified to explain the movement.

21 Jul 2026, 22:51 UTC

Pulse Biosciences Inc shares declined in after-market trading, reversing earlier gains. No specific news was identified to explain the price movement.

20 Jul 2026, 19:26 UTC

Shares of Pulse Biosciences Inc. are lower today, reversing earlier gains amid broader market pressure from rising US Treasury yields and geopolitical uncertainties.

Peer Comparison

Price change

Pulse Biosciences Inc Forecast

Price Target

By TipRanks

-4.64% downside

12 Months Forecast

Average 33.5 USD -4.64%

High 35 USD

Low 32 USD

Based on 2 Wall Street analysts offering 12 month price targets forPulse Biosciences Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

Buy

Hold

Sell

Based on 2 analysts giving stock ratings to Pulse Biosciences Inc - Dist in the past 3 months.

Sentiment

By Acuity

132 / 340 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.